Announcements Trials

Browse Landscape

Phase

Phase 1 4 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 57 Neoplasms 32 Colorectal Neoplasms 32 Neoplasm Metastasis 31 Breast Neoplasms 30 Prostatic Neoplasms 29 Pancreatic Neoplasms 25 Ovarian Neoplasms 24 Multiple Myeloma 23 Recurrence 22 Melanoma 22 Squamous Cell Carcinoma of Head and Neck 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Non-Hodgkin 17 Endometrial Neoplasms 17 Triple Negative Breast Neoplasms 16 Lung Neoplasms 15 Leukemia, Myeloid, Acute 15 Glioblastoma 15 Stomach Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 14 Burkitt Lymphoma 14 Advanced Solid Tumor 13 Small Cell Lung Carcinoma 12 Colonic Neoplasms 12 Carcinoma, Renal Cell 12 Lymphoma, Follicular 11 Lymphoma 11 Advanced Solid Tumors 11 Glioma 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Solid Tumor, Adult × 30 days × Clear all

NCT06977737 2026-05-22

ATTEST

Accession Therapeutics Limited

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡